How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
Key takeaways
- BMY ^GSPC Pharmaceutical giant Bristol Myers Squibb (NYSE: BMY) is offering investors a 4.5% yield.
- Bristol Myers Squibb isn t an upstart drug company; it has been in business for a very long time and is highly respected.
- Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need.
BMY ^GSPC Pharmaceutical giant Bristol Myers Squibb (NYSE: BMY) is offering investors a 4.5% yield. That is well above the 1% you d collect from the S&P 500 index (SNPINDEX: ^GSPC ) and the 1.6% average for the drug sector. While the yield looks relatively attractive, given how high it is, prudent investors will wonder if the dividend is safe. It s highly likely that it is, and here s why.
Bristol Myers Squibb isn t an upstart drug company; it has been in business for a very long time and is highly respected. Notably, its dividend hasn t been increased every year, but it has trended higher for decades. That s an indication of the company s strength as a business and of the board of directors understanding of the dividend s value to shareholders.
Will AI create the world s first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »